LIMINATUS PHARMA INC.
LIMN·53271X108·US·Common Stock·Healthcare - Biotechnology-Activist
LIMN (LIMINATUS PHARMA INC.) is held by 12 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($116,465), GEODE CAPITAL MANAGEMENT, LLC ($20,249), JANE STREET GROUP, LLC ($12,259). Net institutional sentiment: Bullish.
12
Holders
Avg rating(2 Elite)
$183,671
Total Value
69% (14)
Fund Consensus
9 buying - 4 selling
Who's Trading
ActivistVTValetudo Therapeutics LLC14.3%Jul 14, 2026
ActivistECEwon Comfortech Co., Ltd.10.9%Jul 6, 2026
ActivistMPMitchell P. Kopin5.0%Feb 20, 2026
ActivistKFKH Feelux Co., Ltd15.4%Jun 27, 2025
ActivistRPRed Peony Association 1st5.7%Jun 26, 2025
ActivistNANongae Apple Association 1st5.7%Jun 26, 2025
ActivistECEwon Comfortech Co., Ltd.5.8%Jun 26, 2025
ActivistIAIris Acquisition Holdings LLC26.5%May 8, 2025
ActivistVTValetudo Therapeutics LLC23.7%May 7, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer